These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
668 related articles for article (PubMed ID: 3020071)
41. Calcium crystal deposition diseases: update on pathogenesis and manifestations. Molloy ES; McCarthy GM Rheum Dis Clin North Am; 2006 May; 32(2):383-400, vii. PubMed ID: 16716885 [TBL] [Abstract][Full Text] [Related]
42. The role of uric acid and other crystals in osteoarthritis. Nowatzky J; Howard R; Pillinger MH; Krasnokutsky S Curr Rheumatol Rep; 2010 Apr; 12(2):142-8. PubMed ID: 20425024 [TBL] [Abstract][Full Text] [Related]
43. [Identification of crystals in synovial fluid: joint-specific identification rate and correlation with clinical preliminary diagnosis]. Schlapbach P; Pfluger D; Gerber NJ Schweiz Med Wochenschr; 1992 Jun; 122(25):969-74. PubMed ID: 1621079 [TBL] [Abstract][Full Text] [Related]
44. Calcium pyrophosphate dihydrate gout and other crystal deposition diseases. Reginato AJ Curr Opin Rheumatol; 1991 Aug; 3(4):676-83. PubMed ID: 1654974 [TBL] [Abstract][Full Text] [Related]
45. Calcium pyrophosphate and monosodium urate crystal interactions with neutrophils: effect of crystal size and lipoprotein binding to crystals. Burt HM; Jackson JK; Rowell J J Rheumatol; 1989 Jun; 16(6):809-17. PubMed ID: 2550631 [TBL] [Abstract][Full Text] [Related]
46. Advances in understanding calcium-containing crystal disease. Ea HK; Lioté F Curr Opin Rheumatol; 2009 Mar; 21(2):150-7. PubMed ID: 19339926 [TBL] [Abstract][Full Text] [Related]
47. Clinical aspects of calcium pyrophosphate dihydrate crystal deposition. Doherty M; Dieppe P Rheum Dis Clin North Am; 1988 Aug; 14(2):395-414. PubMed ID: 2845493 [TBL] [Abstract][Full Text] [Related]
48. What do I need to know about gout? Becker MA; Ruoff GE J Fam Pract; 2010 Jun; 59(6 Suppl):S1-8. PubMed ID: 20544070 [TBL] [Abstract][Full Text] [Related]
49. Inhibitory effect of low density lipoprotein on the inflammation-inducing activity of calcium pyrophosphate dihydrate crystals. Kumagai Y; Watanabe W; Kobayashi A; Sato K; Onuma S; Sakamoto H J Rheumatol; 2001 Dec; 28(12):2674-80. PubMed ID: 11764217 [TBL] [Abstract][Full Text] [Related]
52. Tophi as first clinical sign of gout. Thissen CA; Frank J; Lucker GP Int J Dermatol; 2008 Nov; 47 Suppl 1():49-51. PubMed ID: 18986488 [TBL] [Abstract][Full Text] [Related]
54. A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis. Perez-Ruiz F; Herrero-Beites AM; Carmona L Arthritis Rheum; 2011 Dec; 63(12):4002-6. PubMed ID: 21898351 [TBL] [Abstract][Full Text] [Related]